Conjugate vaccine

20 marketed 46 in Phase 3 3 in Phase 2

This page covers all Conjugate vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Neisseria meningitidis capsular polysaccharides (serogroups A, C, W, Y), Neisseria meningitidis serogroups A, C, W, and Y, Haemophilus influenzae type b polyribosylribitol phosphate (PRP) capsular antigen.

Targets

Neisseria meningitidis capsular polysaccharides (serogroups A, C, W, Y) · Neisseria meningitidis serogroups A, C, W, and Y · Haemophilus influenzae type b polyribosylribitol phosphate (PRP) capsular antigen · Streptococcus pneumoniae polysaccharide capsule (Prevenar); Neisseria meningitidis serogroup C polysaccharide capsule (Meningitec) · Neisseria meningitidis serogroup C polysaccharide capsule · Neisseria meningitidis serogroup B polysaccharide capsule · Neisseria meningitidis serogroup A polysaccharide capsule · Haemophilus influenzae type b polyribosylribitol phosphate (PRP) capsular polysaccharide · Neisseria meningitidis serogroups A, C, W, Y polysaccharide capsules · Meningococcal antigens

Marketed (20)

Phase 3 pipeline (46)

Phase 2 pipeline (3)